125 related articles for article (PubMed ID: 38479630)
1. Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia.
Bahal S; Zinicola M; Moula SE; Whittaker TE; Schejtman A; Naseem A; Blanco E; Vetharoy W; Hu YT; Rai R; Gomez-Castaneda E; Cunha-Santos C; Burns SO; Morris EC; Booth C; Turchiano G; Cavazza A; Thrasher AJ; Santilli G
J Allergy Clin Immunol; 2024 Mar; ():. PubMed ID: 38479630
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia.
Gray DH; Villegas I; Long J; Santos J; Keir A; Abele A; Kuo CY; Kohn DB
CRISPR J; 2021 Apr; 4(2):191-206. PubMed ID: 33876953
[TBL] [Abstract][Full Text] [Related]
3. Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer.
Yu PW; Tabuchi RS; Kato RM; Astrakhan A; Humblet-Baron S; Kipp K; Chae K; Ellmeier W; Witte ON; Rawlings DJ
Blood; 2004 Sep; 104(5):1281-90. PubMed ID: 15142874
[TBL] [Abstract][Full Text] [Related]
4. B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia.
Kerns HM; Ryu BY; Stirling BV; Sather BD; Astrakhan A; Humblet-Baron S; Liggitt D; Rawlings DJ
Blood; 2010 Mar; 115(11):2146-55. PubMed ID: 20093406
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID mice.
Moreau T; Bardin F; Barlogis V; Le Deist F; Chabannon C; Tonnelle C
Cytotherapy; 2009; 11(2):198-205. PubMed ID: 19235603
[TBL] [Abstract][Full Text] [Related]
6. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1.
Schiroli G; Ferrari S; Conway A; Jacob A; Capo V; Albano L; Plati T; Castiello MC; Sanvito F; Gennery AR; Bovolenta C; Palchaudhuri R; Scadden DT; Holmes MC; Villa A; Sitia G; Lombardo A; Genovese P; Naldini L
Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021165
[TBL] [Abstract][Full Text] [Related]
7. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.
Brault J; Liu T; Liu S; Lawson A; Choi U; Kozhushko N; Bzhilyanskaya V; Pavel-Dinu M; Meis RJ; Eckhaus MA; Burkett SS; Bosticardo M; Kleinstiver BP; Notarangelo LD; Lazzarotto CR; Tsai SQ; Wu X; Dahl GA; Porteus MH; Malech HL; De Ravin SS
Front Immunol; 2022; 13():1067417. PubMed ID: 36685559
[TBL] [Abstract][Full Text] [Related]
9. Case Report: A Case of X-Linked Agammaglobulinemia With High Serum IgE Levels and Allergic Rhinitis.
Cinicola B; Uva A; Leonardi L; Moratto D; Giliani S; Carsetti R; Ferrari S; Zicari AM; Duse M
Front Immunol; 2020; 11():582376. PubMed ID: 33224144
[TBL] [Abstract][Full Text] [Related]
10. Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man.
Hendriks RW; Bredius RG; Pike-Overzet K; Staal FJ
Expert Opin Ther Targets; 2011 Aug; 15(8):1003-21. PubMed ID: 21635151
[TBL] [Abstract][Full Text] [Related]
11. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
12. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
13. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
14. Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus.
Luk ADW; Ni K; Wu Y; Lam KT; Chan KW; Lee PP; Tu W; Mao H; Lau YL
Front Immunol; 2018; 9():1826. PubMed ID: 30147693
[TBL] [Abstract][Full Text] [Related]
15. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
16. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
[TBL] [Abstract][Full Text] [Related]
17. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.
Noordzij JG; de Bruin-Versteeg S; Comans-Bitter WM; Hartwig NG; Hendriks RW; de Groot R; van Dongen JJ
Pediatr Res; 2002 Feb; 51(2):159-68. PubMed ID: 11809909
[TBL] [Abstract][Full Text] [Related]
18. Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector.
Seymour BJ; Singh S; Certo HM; Sommer K; Sather BD; Khim S; Clough C; Hale M; Pangallo J; Ryu BY; Khan IF; Adair JE; Rawlings DJ
Mol Ther Methods Clin Dev; 2021 Mar; 20():635-651. PubMed ID: 33718514
[TBL] [Abstract][Full Text] [Related]
19. Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for
van Zelm MC; Pumar M; Shuttleworth P; Aui PM; Smart JM; Grigg A; Bosco JJ
Front Immunol; 2019; 10():895. PubMed ID: 31105705
[TBL] [Abstract][Full Text] [Related]
20. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
Brunner C; Kreth HW; Ochs HD; Schuster V
J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
